Mira1a Therapeutics, Inc. (CIK: 0001904286) EDGAR, Information, Filings... CompaniesBIO.Com

Mira1a Therapeutics, Inc.

Mailing address
324 SOUTH HYDE PARK AVENUE, SUITE 350, TAMPA, Florida, 33606
Phone
813-369-5150
State location
Maryland
State of incorporation
Florida
Fiscal year end
N/A
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Mira1a Therapeutics, Inc. (CIK: 0001904286) is an American company incorporated in the state of Maryland. Head office is located at 855 N WOLFE STREET #623-6, BALTIMORE, Maryland, 21205. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Mira1a Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Chapman Christopher C JR	0001340428	Aug-02-2023	director, officer: Executive Chairman
Vorhoff David C	0001342020	Aug-02-2023	director
Kaplin Adam	0001858042	Aug-02-2023	officer: Pres. & Chief Scientific Off.
McColl Hugh III	0001934476	Aug-02-2023	director
Yanez Michelle	0001958023	Aug-02-2023	officer: CFO, Secretary & Treasurer
Nicholoudis Christos	0001984816	Aug-02-2023	director
Kroenig Bradley	0001985521	Aug-02-2023	director
Aminov Erez	0001986112	Aug-02-2023	director, officer: Chief Executive Officer
Tuck Talhia	0001986139	Aug-02-2023	director
Cappy George	0001986372	Aug-02-2023	10 percent owner
Bay Shore Trust	0001986593	Aug-02-2023	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Mira1a Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001493152-24-034584 ( Act) Size: 65 KB	Aug-30-2024
8-K	Document	Current report filing Acc-no: 0001493152-24-033718 (34 Act) Size: 216 KB	Aug-23-2024	001-41765 241236506
EFFECT	Document	Acc-no: 9999999995-24-002570 (33 Act) Size: 1 KB	Aug-16-2024	333-281467 241218145
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-24-032816 (34 Act) Size: 6411 KB	Aug-16-2024	001-41765 241216699
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-24-031612 (34 Act) Size: 6280 KB	Aug-13-2024	001-41765 241201409
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0001493152-24-031171 (33 Act) Size: 1248 KB	Aug-12-2024	333-281467 241195014
8-K	Document	Current report filing Acc-no: 0001493152-24-030980 (34 Act) Size: 211 KB	Aug-09-2024	001-41765 241192932
8-K	Document	Current report filing Acc-no: 0001493152-24-030684 (34 Act) Size: 201 KB	Aug-08-2024	001-41765 241186275
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001493152-24-029265 (34 Act) Size: 1263 KB	Jul-26-2024	001-41765 241147838
DEF 14A	Document	Definitive proxy statements Acc-no: 0001493152-24-029259 (34 Act) Size: 1936 KB	Jul-26-2024	001-41765 241147713
8-K	Document	Current report filing Acc-no: 0001493152-24-028917 (34 Act) Size: 216 KB	Jul-24-2024	001-41765 241138141
8-K	Document	Current report filing Acc-no: 0001493152-24-028548 (34 Act) Size: 212 KB	Jul-19-2024	001-41765 241128473
8-K	Document	Current report filing Acc-no: 0001493152-24-027120 (34 Act) Size: 231 KB	Jul-12-2024	001-41765 241115128
8-K	Document	Current report filing Acc-no: 0001493152-24-025643 (34 Act) Size: 310 KB	Jun-28-2024	001-41765 241086615
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001493152-24-024753 ( Act) Size: 6 KB	Jun-21-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001493152-24-022029 ( Act) Size: 6 KB	May-30-2024
8-K	Document	Current report filing Acc-no: 0001493152-24-021731 (34 Act) Size: 210 KB	May-29-2024	001-41765 24994105
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001493152-24-021069 ( Act) Size: 15 KB	May-22-2024
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-24-018908 (34 Act) Size: 2535 KB	May-13-2024	001-41765 24939602
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-24-012141 (34 Act) Size: 11060 KB	Apr-01-2024	001-41765 24805503

Recent 20 filings. View all Mira1a Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Mira1a Therapeutics, Inc. overview
Mira1a Therapeutics, Inc. job
Mira1a Therapeutics, Inc. stock
Mira1a Therapeutics, Inc. ownership
Mira1a Therapeutics, Inc. CEO
Mira1a Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.